Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis
Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC
Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer
Breast Cancer Rates Decline Most for Affluent White Women
Low Prevalence Of Tamoxifen Use For Cancer Prevention
Symptoms Don’t Help Detect Early-Stage Ovarian Cancer
Two-Week Break Balances RT Palliation, Side Effects
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Harvey Risch, critic of COVID-19 response, tapped by White House to serve as chair of the President’s Cancer Panel
- Brown University reaches agreement with Trump administration to restore funding
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC









